rare diseases – Benefits Canada.com https://uat-cumulus.benefitscanada.com Canada's most influential pension and benefits publication for decision-makers Thu, 16 Jan 2025 20:41:36 +0000 en-US hourly 1 https://wordpress.org/?v=4.9.8 How is the pandemic, policy issues impacting group benefits and pharmaceutical industries? https://uat-cumulus.benefitscanada.com/benefits/health-benefits/how-is-the-pandemic-policy-issues-impacting-group-benefits-and-pharmaceutical-industries/ Mon, 22 Nov 2021 14:00:25 +0000 https://www.benefitscanada.com/?p=112065 The proposed amendments to the patented medicines regulations by the Patented Medicine Prices Review Board could have a big impact on both the group insurance and pharmaceutical industry. “The CLHIA is very supportive of PMPRB adjustments that may be coming,” said Joan Weir, director of health and disability policy at the Canadian Life and Health […]

The post How is the pandemic, policy issues impacting group benefits and pharmaceutical industries? appeared first on Benefits Canada.com.

]]> Possible national pharmacare program has pros, cons for employers: experts https://uat-cumulus.benefitscanada.com/benefits/health-benefits/possible-national-pharmacare-program-has-pros-cons-for-employers-experts/ Wed, 18 Aug 2021 13:00:51 +0000 https://www.benefitscanada.com/?p=105876 Discussion around implementing a national universal pharmacare strategy is growing louder ahead of next month’s federal election. In its 2019 budget, the federal government said it would work with partners to move forward on a national pharmacare program, including the creation of a new national drug agency and formulary, as well as a national strategy for […]

The post Possible national pharmacare program has pros, cons for employers: experts appeared first on Benefits Canada.com.

]]>